BioLargo, Inc.
BLGO
$0.219
-$0.0027-1.22%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -15.05% | -10.61% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -15.05% | -10.61% | |||
| Cost of Revenue | -23.86% | -6.61% | |||
| Gross Profit | -4.50% | -14.97% | |||
| SG&A Expenses | 5.04% | -0.89% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -10.76% | -2.69% | |||
| Operating Income | 3.22% | -15.22% | |||
| Income Before Tax | 2.03% | -10.91% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2.03% | -10.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -9.92% | 6.69% | |||
| Net Income | -3.20% | -13.91% | |||
| EBIT | 3.22% | -15.22% | |||
| EBITDA | 1.22% | -14.47% | |||
| EPS Basic | -2.63% | -11.76% | |||
| Normalized Basic EPS | -14.29% | -16.67% | |||
| EPS Diluted | -2.63% | -11.76% | |||
| Normalized Diluted EPS | -14.29% | -16.67% | |||
| Average Basic Shares Outstanding | 0.64% | 0.02% | |||
| Average Diluted Shares Outstanding | 0.64% | 0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||